On March 4, Nordic Capital, a Swedish private equity group, announced that it acquired CARE Fertility, the United Kingdom’s leading fertility clinic group, specifically focusing on IVF treatment.
Nordic Capital is a leader in Nordic private equity investments that has invested upwards of $20 billion in more than 120 companies. While CARE Fertility has been at the forefront of IVF science and clinical technology for over 25 years. The company has an outstanding reputation based on its excellent success rates, high medical standards and clinical leadership. It has 23 locations across the United Kingdom.
Global law firm White & Case LLP advised Nordic Capital on the transaction, but terms of the deal were not disclosed.
This acquisition is the 109th physician medical group transaction of 2022, and the tenth fertility clinic to be acquired. Of those acquirers, five of them are private equity companies such as Ivy Fertility. As is typical with many private equity and PMG transactions, very few prices have been disclosed. The only deal to have an announced purchase price was Partners Group acquiring Forefront Dermatology, in February, for a substantial $1.5 billion. We went into this deal in greater detail in our monthly healthcare newsletter, which you can read here.
When looking at the PMG deals from the same time period of last year (January to March 9, 2021) the deal quantity is similar with only 99 deals reported. Of those 99 deals, only 2 of them were for fertility clinics but many of the acquirers have been private equity companies. From this, it can be inferred that while PMGs, in general, are maintaining consistency, there is a possibility that fertility clinics have become more interesting for buyers and offer greater opportunity than past years.
